STAGE IV INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Clinical trials for STAGE IV INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radiation beads plus immunotherapy: a new hope for inoperable bile duct cancer?
Disease control Recruiting nowThis early-phase trial is testing whether combining a targeted radiation treatment (Y90 radioembolization) with two immunotherapy drugs (durvalumab and tremelimumab) is safe and shows promise for people with bile duct cancer that cannot be removed by surgery. The study will enrol…
Matched conditions: STAGE IV INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 23, 2026 19:32 UTC
-
New combo therapy for unresectable liver cancer shows promise in early trial
Disease control Recruiting nowThis study tests a new treatment for people with advanced liver cancer that cannot be removed by surgery. The approach combines high-dose radiation, a personalized vaccine made from the patient's own immune cells, and immunotherapy drugs to help the body fight the tumor. The goal…
Matched conditions: STAGE IV INTRAHEPATIC CHOLANGIOCARCINOMA AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 22, 2026 12:03 UTC